Search - tctmd.com

Displaying 121 - 136 of 136

Sort: Relevancy | Date

Presentation TCT 2014

Updates and Status of the St. Jude EnligHTN Program

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray

September 14, 2014

Presentation TCT 2014

Updates and Status of the Boston Scientific Vessix Program

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, Ajay J. Kirtane

September 14, 2014

Presentation TCT 2014

From SYMPLICITY HTN-1 to the Global SYMPLICITY Registry and Beyond: Updates from and Status of the SYMPLICITY Clinical Trial Program

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, Michael Boehm

September 14, 2014

Presentation TCT 2014

TCT 405: SYMPLICITY HTN-3: Outcomes in the African-American and NonAfrican American Populations

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, John Flack

September 14, 2014

Presentation TCT 2014

First Deep Dive into SYMPLICITY HTN-3: Primary Results and Updated Analyses

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray

September 14, 2014

Presentation LAA 2014

Safety and Efficacy of the WAVECREST: First-in-Human Experiences and Future Trials

Presenter: Gregg W. Stone

July 19, 2014

Presentation LAA 2014

LARIAT: Clinical Trial Results & Future Trials

Presenter: Steven J. Yakubov

July 19, 2014

Presentation Cell Therapy 2014

Future of Clinical Trials: Patient-Specific Stem Cells in a Dish

Presenter: Joseph C. Wu

January 22, 2014

Presentation TCT 2013

Impact of Lesion Complexity on Outcomes in Drug-Coated Balloon Trials: Implications for Device Selection and Future Trial Design

Presenter: Gunnar Tepe

October 31, 2013

Presentation TCT 2013

Lessons Learned from PARTNER 2A and SURTAVI: Device Specificity, Trial Design, Endpoints, and Future Low-risk Studies

Presenter: Jodi Akin

October 30, 2013

Presentation TCT 2013

Insights from the TWENTE Series of Clinical Trials: Past, Present, and Future

Presenter: Clemens von Birgelen

October 28, 2013

Presentation TCT 2013

Insights from the SORT-OUT Series of Clinical Trials: Past, Present, and Future

Presenter: Lisette Okkels Jensen

October 28, 2013

Presentation TCT 2013

Insights from the COMPARE Series of Clinical Trials: Past, Present, and Future

Presenter: Peter Smits

October 28, 2013

Presentation TCT 2013

The Spectrum of Current and Future Renal Denervation Clinical Trials

Presenter: Mehdi Shishehbor

October 27, 2013

Presentation TCT 2012

A View to Future Trials: HORIZONS-AMI II and Others

Presenter: Roxana Mehran

October 24, 2012

Presentation TCT 2012

The Utility of Three Primary Prevention Scoring Systems (Framingham, PROCAM, and SCORE) in Predicting Future Events in Patients with Acute Coronary Syndromes: The PROSPECT Trial

Presenter: Jung-Won Suh, Gary S. Mintz, Giora Weisz, Akiko Maehara, Ke Xu, Alexandra J. Lansky, Ecaterina Cristea, Roxana Mehran, John McPherson, Naim Farhat, Steven P. Marso, Bernard de Bruyne, Patrick W. Serruys, Gregg W. Stone

January 03, 2012

Advertisement

Updates and Status of the St. Jude EnligHTN Program

Updates and Status of the Boston Scientific Vessix Program

From SYMPLICITY HTN-1 to the Global SYMPLICITY Registry and Beyond: Updates from and Status of the SYMPLICITY Clinical Trial Program

TCT 405: SYMPLICITY HTN-3: Outcomes in the African-American and NonAfrican American Populations

First Deep Dive into SYMPLICITY HTN-3: Primary Results and Updated Analyses

Safety and Efficacy of the WAVECREST: First-in-Human Experiences and Future Trials

LARIAT: Clinical Trial Results & Future Trials

Future of Clinical Trials: Patient-Specific Stem Cells in a Dish

Impact of Lesion Complexity on Outcomes in Drug-Coated Balloon Trials: Implications for Device Selection and Future Trial Design

Lessons Learned from PARTNER 2A and SURTAVI: Device Specificity, Trial Design, Endpoints, and Future Low-risk Studies

Insights from the TWENTE Series of Clinical Trials: Past, Present, and Future

Insights from the SORT-OUT Series of Clinical Trials: Past, Present, and Future

Insights from the COMPARE Series of Clinical Trials: Past, Present, and Future

The Spectrum of Current and Future Renal Denervation Clinical Trials

A View to Future Trials: HORIZONS-AMI II and Others

The Utility of Three Primary Prevention Scoring Systems (Framingham, PROCAM, and SCORE) in Predicting Future Events in Patients with Acute Coronary Syndromes: The PROSPECT Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content